Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

AstraZeneca
Julphar
Colorcon
Medtronic
Accenture
Fish and Richardson

Generated: March 19, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Metreleptin

« Back to Dashboard

US Patents for Metreleptin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Metreleptin ➤ Sign Up Methods of treating obesity with two different anti-obesity agents Amylin Pharmaceuticals LLC (San Diego, CA) AstraZeneca Pharmaceuticals LP (Wilmington, DE) ➤ Sign Up
Metreleptin ➤ Sign Up FZD8 extracellular domains and FZD8 extracellular domain fusion molecules and treatments using same Five Prime Therepeutics, Inc. (South San Francisco, CA) ➤ Sign Up
Metreleptin ➤ Sign Up Pyrrolidinone derivatives as GPR119 modulators for the treatment of diabetes, obesity, dyslipidemia and related disorders Sanofi (Paris, FR) ➤ Sign Up
Metreleptin ➤ Sign Up ➤ Sign Up
Metreleptin ➤ Sign Up Combination therapy Boehringer Ingelheim International GmbH (Ingelheim am Rhein, DE) ➤ Sign Up
Drugname Patent Number Patent Title Patent Assignee Estimated Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

International Patents for Metreleptin

Drugname Country Document Number Estimated Expiration Related US Patent
Metreleptin Austria 427759 2024-11-01 ➤ Sign Up
Metreleptin Austria 439140 2024-11-01 ➤ Sign Up
Metreleptin Austria 480255 2024-11-01 ➤ Sign Up
Metreleptin Australia 2005305036 2024-11-01 ➤ Sign Up
Metreleptin Australia 2006230420 2024-11-01 ➤ Sign Up
Drugname Country Document Number Estimated Expiration Related US Patent

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving hundreds of leading biopharmaceutical companies globally:

QuintilesIMS
Boehringer Ingelheim
Moodys
Federal Trade Commission
US Department of Justice
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.